Crusted scabies in two immunocompromised children: successful treatment with oral ivermectin

Australas J Dermatol. 1999 Feb;40(1):37-40. doi: 10.1046/j.1440-0960.1999.00314.x.


Two immunodeficient children, aged 4 and 12 years, with crusted scabies were successfully treated with a single oral dose of ivermectin (200 micrograms/kg). One child had been diagnosed in infancy with an undefined congenital T cell immunodeficiency and the other with chronic mucocutaneous candidiasis. Both had failed to respond to conventional topical therapy. In view of the excellent therapeutic response and absence of side-effects, ivermectin should be considered in the treatment of recalcitrant crusted scabies in children.

Publication types

  • Case Reports

MeSH terms

  • Administration, Oral
  • Antinematodal Agents / administration & dosage*
  • Child
  • Child, Preschool
  • Female
  • Follow-Up Studies
  • Humans
  • Immunocompromised Host*
  • Ivermectin / administration & dosage*
  • Male
  • Scabies / diagnosis
  • Scabies / drug therapy*
  • Scabies / immunology*
  • Treatment Outcome


  • Antinematodal Agents
  • Ivermectin